Peripheral Intravenous (IV) Catheters

Global Peripheral Intravenous (IV) Catheters Market to Reach US$7.7 Billion by 2030

The global market for Peripheral Intravenous (IV) Catheters estimated at US$5.6 Billion in the year 2024, is expected to reach US$7.7 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2024-2030. Short Catheters, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$4.6 Billion by the end of the analysis period. Growth in the Integrated / Closed Catheters segment is estimated at 6.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.5 Billion While China is Forecast to Grow at 8.9% CAGR

The Peripheral Intravenous (IV) Catheters market in the U.S. is estimated at US$1.5 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2030 trailing a CAGR of 8.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.2% and 5.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Global Peripheral Intravenous (IV) Catheters Market - Key Trends and Drivers Summarized

Peripheral Intravenous (IV) Catheters are essential medical devices used extensively in healthcare settings for the administration of medications, fluids, electrolytes, and nutritional compounds directly into a patient`s venous system. Their primary function is to provide immediate access to the bloodstream, facilitating rapid absorption and effect of administered substances. These catheters are most commonly placed in peripheral veins such as those in the arms or hands, but alternative sites can include the scalp veins in infants or the feet in adults when other sites are not viable. The catheter itself consists of a flexible tube that is inserted into a vein using a needle, which is subsequently removed, leaving only the tube in place. This setup minimizes the patient`s discomfort and maintains an open channel to the bloodstream for the required duration of treatment, which can range from a few hours to several weeks, depending on the clinical situation.

The design and material composition of peripheral IV catheters have evolved to enhance patient safety and comfort. Traditionally made from polyurethane or silicone, these catheters are designed to be biocompatible to reduce the risk of venous irritation and minimize the likelihood of allergic reactions. Recent innovations include the development of catheters with antimicrobial and antithrombotic coatings to reduce the incidence of catheter-related bloodstream infections and thrombosis, respectively. Furthermore, the use of safety-engineered devices with retractable needles has become more widespread, significantly reducing the incidence of needlestick injuries among healthcare providers. These catheters come in various gauges and lengths, allowing for customization based on patient needs and the viscosity of the infused substance, thus optimizing the flow rates and reducing the risks of complications.

The growth in the peripheral intravenous catheter market is driven by several factors, including advancements in catheter technology, an increase in the prevalence of chronic diseases, and a rising emphasis on healthcare quality and patient safety. The aging population globally has led to a higher incidence of chronic conditions such as diabetes, cancer, and cardiovascular diseases, all of which often require IV therapeutic treatment modalities. Additionally, the growing trend towards minimally invasive treatments has fueled the demand for devices that can be efficiently managed in outpatient settings, including home healthcare. The market is also benefiting from the increasing investment in healthcare infrastructure and services, particularly in emerging economies where access to basic medical care is expanding. Furthermore, ongoing research and development activities aimed at further minimizing infection rates and improving patient comfort are poised to propel the adoption of newer, more advanced peripheral IV catheter products. This market dynamic is supported by a competitive landscape where manufacturers are continually innovating to meet the stringent safety standards required by regulatory authorities worldwide, ensuring sustained growth in this sector.

SCOPE OF STUDY:

The report analyzes the Peripheral Intravenous (IV) Catheters market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product (Short Catheters, Integrated / Closed Catheters); Technology (Safety Peripheral Intravenous Catheters, Conventional Peripheral Intravenous Catheters); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 45 Featured) -

• Argon Medical Devices, Inc.
• B. Braun Medical Inc.
• Becton, Dickinson and Company
• ICU Medical, Inc.
• MEDEREN Neotech Ltd
• Nipro Medical Corporation
• Delta Med S.p.A
• Vogt Medical GMBH
• Teleflex, Inc.
• Terumo Medical Corporation
• Vygon SAS

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.